Qualigen Therapeutics Inc
NASDAQ:QLGN
Qualigen Therapeutics Inc
NASDAQ:QLGN
Price:
2.33
USD
0.3%
Market Cap:
$4.7m
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
Qualigen Therapeutics Inc
NASDAQ:QLGN
|
US |
|
Crescent Biopharma Inc (Pre-Reincorporation)
NASDAQ:CBIO
|
US |
|
ams OSRAM AG
SIX:AMS
|
AT |
|
DaFa Properties Group Ltd
HKEX:6111
|
CN |
Multiples-Based Value
The Multiples-Based Value of one
QLGN
stock under the Base Case scenario is
hidden
USD.
Compared to the current market price of 2.33 USD,
Qualigen Therapeutics Inc
is
hidden
.
Multiples-Based Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Relative Valuation FAQ:
QLGN Multiples-Based Value
LOCKED
Multiples Across Competitors
QLGN Competitors Multiples
Qualigen Therapeutics Inc Competitors
Qualigen Therapeutics Inc Competitors
All Countries
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| US |
|
Qualigen Therapeutics Inc
NASDAQ:QLGN
|
4.7m USD | 0 | -0.7 | -1.3 | -1.3 | |
| FR |
|
Pharnext SCA
OTC:PNEXF
|
6T USD | 33 690 872.8 | -160 127.7 | -194 446.1 | -192 227.3 | |
| US |
|
Abbvie Inc
NYSE:ABBV
|
364.8B USD | 6.1 | 88.7 | 14.7 | 20.4 | |
| US |
|
Amgen Inc
NASDAQ:AMGN
|
183.3B USD | 5.1 | 24.2 | 14.1 | 14.1 | |
| US |
|
Gilead Sciences Inc
NASDAQ:GILD
|
172.3B USD | 5.9 | 20.5 | 12.8 | 15.8 | |
| US |
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
109.7B USD | 9.3 | 28.3 | 21.2 | 22.2 | |
| US |
E
|
Epizyme Inc
F:EPE
|
94.1B EUR | 2 091 | -533.6 | -581 | -565.5 | |
| US |
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
80.4B USD | 5.7 | 18 | 13.5 | 15.4 | |
| AU |
|
CSL Ltd
ASX:CSL
|
67.6B AUD | 3 | 33.6 | 11.3 | 14.2 | |
| NL |
|
argenx SE
XBRU:ARGX
|
39.7B EUR | 11.6 | 37.3 | 40.7 | 41.5 | |
| US |
S
|
Seagen Inc
F:SGT
|
39.3B EUR | 20.1 | -61.8 | -66.6 | -60.1 |
P/S Multiple
P/E Multiple
EV/EBITDA Multiple
EV/EBIT Multiple
